RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...

RBC Capital Markets adjusted its stance on CF Industries Holdings Inc. (NYSE:CF), downgrading the stock from 'Outperform' to ...

SAGE Therapeutics Inc (SAGE) stock saw a modest uptick, ending the day at $7.08 which represents a slight increase of $0.11 or 1.58% from the prior close of $6.97. The stock opened at $7.02 and ...

RBC Capital analyst Gerard Cassidy maintained a Buy rating on Regions Financial (RF – Research Report) on January 17 and set a price target of ...

RBC Bearings RBC +1.20% Get Free Report has outperformed the market over the past 15 years by 6.93% on an annualized basis ...

Most readers would already know that RBC Bearings' (NYSE:RBC) stock increased by 9.7% over the past three months. As... Despite weakness in the manufacturing sector, recovery in the demand ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Boston Scientific (BSX – Research Report), with ...

Mihelic hiked his price target on Toronto-listed BMO shares from $133 to $161, while upgrading his rating to “Outperform” ...